User:Kylie Blake/Sandbox 1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 28: Line 28:
<ref name="Thapa">Thapa, G., Kumari, A., Dasgupta, D., Bandyopadhy, S., Sarkar, N., Roy, K., Karunakaran, G., Kazmi, I., Karmakar, S., & Chakraborty, M. (2023). Chapter 5- Insight into the mechanism of action of anti-diabetic drugs. ''How Synthetic Drugs Work.'' 95-122. [http://dx.doi.org/10.1016/B978-0-323-99855-0.00005-1 DOI: 10.1016/B978-0-323-99855-0.00005-1]</ref>
<ref name="Thapa">Thapa, G., Kumari, A., Dasgupta, D., Bandyopadhy, S., Sarkar, N., Roy, K., Karunakaran, G., Kazmi, I., Karmakar, S., & Chakraborty, M. (2023). Chapter 5- Insight into the mechanism of action of anti-diabetic drugs. ''How Synthetic Drugs Work.'' 95-122. [http://dx.doi.org/10.1016/B978-0-323-99855-0.00005-1 DOI: 10.1016/B978-0-323-99855-0.00005-1]</ref>
 +
<ref name="Press"> Press, M., Jung, T., Konig, J., Grune, T., & Hohn, A. (2019). Protein aggregates and proteostasis in aging: Amylin and β-cell function. ''Mechanisms of Ageing and Development. 3,'' 46-54. [http://dx.doi.org/10.1016/j.mad.2018.03.010 DOI: 10.1016/j.mad.2018.03.010]</ref>
 +
 +
DOI:10.1016/j.mad.2018.03.010
Line 48: Line 51:
<ref name="Mathiesen">
<ref name="Mathiesen">
<ref name="Thapa">
<ref name="Thapa">
 +
<ref name="Press">

Revision as of 21:40, 24 April 2024

Amylin Receptor, AMYr, Protein

AMYR 7TYF

Drag the structure with the mouse to rotate

References

  1. Cao J, Belousoff MJ, Liang YL, Johnson RM, Josephs TM, Fletcher MM, Christopoulos A, Hay DL, Danev R, Wootten D, Sexton PM. A structural basis for amylin receptor phenotype. Science. 2022 Mar 25;375(6587):eabm9609. PMID:35324283 doi:10.1126/science.abm9609
  2. Hay DL, Chen S, Lutz TA, Parkes DG, Roth JD. Amylin: Pharmacology, Physiology, and Clinical Potential. Pharmacol Rev. 2015 Jul;67(3):564-600. PMID:26071095 doi:10.1124/pr.115.010629
  3. Grizzanti J, Corrigan R, Casadesus G. Neuroprotective Effects of Amylin Analogues on Alzheimer's Disease Pathogenesis and Cognition. J Alzheimers Dis. 2018;66(1):11-23. PMID:30282360 doi:10.3233/JAD-180433
  4. Cao J, Belousoff MJ, Liang YL, Johnson RM, Josephs TM, Fletcher MM, Christopoulos A, Hay DL, Danev R, Wootten D, Sexton PM. A structural basis for amylin receptor phenotype. Science. 2022 Mar 25;375(6587):eabm9609. PMID:35324283 doi:10.1126/science.abm9609
  5. Mathiesen DS, Lund A, Vilsbøll T, Knop FK, Bagger JI. Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat. Front Endocrinol (Lausanne). 2021 Jan 8;11:617400. PMID:33488526 doi:10.3389/fendo.2020.617400
  6. Thapa, G., Kumari, A., Dasgupta, D., Bandyopadhy, S., Sarkar, N., Roy, K., Karunakaran, G., Kazmi, I., Karmakar, S., & Chakraborty, M. (2023). Chapter 5- Insight into the mechanism of action of anti-diabetic drugs. How Synthetic Drugs Work. 95-122. DOI: 10.1016/B978-0-323-99855-0.00005-1
  7. Press, M., Jung, T., Konig, J., Grune, T., & Hohn, A. (2019). Protein aggregates and proteostasis in aging: Amylin and β-cell function. Mechanisms of Ageing and Development. 3, 46-54. DOI: 10.1016/j.mad.2018.03.010

[1] [2]

Proteopedia Page Contributors and Editors (what is this?)

Kylie Blake

Personal tools